A cholesteatoma is not a tumor. It is a non-cancerous, non-neoplastic growth of skin cells trapped in the wrong place, typically behind the eardrum or within the middle ear. The name itself is misleading: “cholesteatoma” literally translates to “cholesterol fat tumor,” a term coined in 1838 by Johannes Müller, who mistakenly believed the lesion was made of fatty tissue. In reality, a cholesteatoma contains neither cholesterol nor fat, and it has no tumor biology whatsoever.
What a Cholesteatoma Actually Is
A cholesteatoma is best understood as a cyst-like pocket of skin growing where skin doesn’t belong. Normal skin on the outside of your ear canal constantly sheds dead cells, which fall away harmlessly. When that same type of skin ends up trapped inside the middle ear or the bone behind it, the dead cells have nowhere to go. They accumulate into an expanding mass surrounded by a fibrous lining, usually accompanied by ongoing inflammation.
Under a microscope, the structure looks remarkably similar to an epidermal inclusion cyst, the kind of benign lump that can form under the skin anywhere on your body. The key material inside is keratin, the same protein that makes up your hair and fingernails. Some clinicians prefer the more accurate name “keratoma,” though “cholesteatoma” remains the standard term.
The critical distinction from a tumor is that cholesteatomas don’t involve uncontrolled cell division or any risk of spreading to distant organs. They are, however, locally destructive. As the trapped skin debris expands, it erodes into surrounding bone, which is what makes cholesteatomas dangerous despite not being cancerous.
How It Destroys Bone Without Being Cancer
The bone erosion caused by a cholesteatoma comes from inflammation rather than malignancy. As the mass grows, the body mounts a chronic inflammatory response against the trapped debris. This triggers the release of collagenase, an enzyme that breaks down collagen, the structural protein in bone. Once collagen is damaged, other enzymes finish the job, gradually dissolving the surrounding bone.
The inflammatory process also activates osteoclasts, the specialized cells your body normally uses to remodel bone. Nitric oxide produced at the site further ramps up osteoclast activity, accelerating bone loss. This is the same basic process that causes bone thinning in other chronic inflammatory conditions, just concentrated in the tiny, delicate structures of the middle ear where even small amounts of erosion can cause serious problems.
Congenital vs. Acquired Types
Cholesteatomas fall into two categories. Congenital cholesteatomas are present from birth, forming when skin cells get trapped behind an intact eardrum during fetal development. These are rare and often discovered incidentally during childhood.
Acquired cholesteatomas are far more common and typically develop after repeated ear infections, a perforated eardrum, or poor function of the eustachian tube. When the eardrum retracts inward due to negative pressure in the middle ear, it can create a pocket that traps skin cells. Over months or years, that pocket deepens and begins accumulating debris.
Symptoms to Recognize
The classic presentation is painless ear drainage that keeps coming back or never fully clears up. The discharge typically has a foul smell and doesn’t respond to standard ear drops or antibiotics. Progressive hearing loss is the other hallmark, caused by the mass physically disrupting the tiny bones that conduct sound. In larger cholesteatomas, the keratin debris itself can interfere with sound transmission even before the bones are damaged.
Because the growth is slow, many people live with mild symptoms for years before seeking care. Dizziness can develop if the erosion reaches the inner ear.
Potential Complications
Left untreated, a cholesteatoma can erode into critical structures. About 3% of patients in the general population develop facial nerve paralysis, though that number jumps dramatically in advanced cases, reaching roughly 40% among patients with severe disease. Intracranial complications, including meningitis, brain abscess, and blood clots in the veins near the brain, occur in about 9% of the general cholesteatoma population and around 14% of those with advanced disease. These numbers underscore why a growth that isn’t cancer still demands treatment.
How It’s Diagnosed
An ear, nose, and throat specialist can often spot a cholesteatoma during a physical exam using an otoscope. High-resolution CT scanning of the temporal bone is the standard imaging tool for confirming the diagnosis and mapping the extent of bone erosion. The cholesteatoma itself doesn’t have a unique appearance on CT, so the diagnosis relies on where the mass sits, whether nearby bones have eroded, and whether the tiny middle ear bones have shifted out of position.
MRI with a specialized technique called non-echoplanar diffusion-weighted imaging has become increasingly useful, with sensitivity and specificity between 80% and 100%. This type of MRI is particularly helpful for detecting whether a cholesteatoma has come back after surgery, since it can distinguish scar tissue from recurrent disease. One limitation: growths smaller than about 2 to 3 millimeters can be missed.
Surgery Is the Only Real Treatment
There is no medication that eliminates a cholesteatoma. Surgery is the standard treatment, with the goal of completely removing the trapped skin and debris while preserving or reconstructing hearing when possible. About 81% of patients are treated surgically, while a small number with very early or limited disease may be managed with repeated in-office cleaning.
The most common procedures involve some form of mastoidectomy, where the surgeon opens the bone behind the ear to access and remove the growth. Techniques vary depending on the size and location of the cholesteatoma. Some approaches preserve the ear canal wall for a more natural result, while others take part of it down to give the surgeon better access and reduce the chance of recurrence. Research over long follow-up periods suggests that a single-stage procedure removing part of the canal wall provides the best long-term outcomes for most patients.
Recurrence Is Common
One of the most important things to understand about cholesteatoma is that it frequently comes back. A large study following over 1,000 patients for more than 33 years found that within five years of surgery, 37% of children and 15% of adults experienced recurrence. Children who needed more extensive surgery had recurrence rates as high as 58%.
This is why long-term follow-up matters. Current recommendations suggest surveillance for at least five years after surgery, with some recurrences appearing nearly five years out. Follow-up typically involves periodic exams and, in many cases, repeat MRI to catch regrowth before it causes new damage. The high recurrence rate is not a failure of surgery so much as a reflection of how persistent the underlying problem can be, especially when the eustachian tube dysfunction or chronic inflammation that caused the original cholesteatoma is still present.